AbCellera announced it has broken ground on an expanded global headquarters in its home city of Vancouver in anticipation of adding hundreds of employees to its current 250-person workforce over the next few years. Located on 4th Avenue between Columbia and Manitoba Streets in Mount Pleasant, the company’s planned tech campus includes two facilities totaling 380,000 square feet that will be developed in partnership with the Dayhu Group and Beedie. The facilities are expected to be completed in 2023 and 2024. AbCellera’s long-term vision in Vancouver includes building Canada’s first clinical-grade Good Manufacturing Practice (GMP) antibody manufacturing facility, which will provide technology and infrastructure to help Canada respond to future pandemics. Vancouver is a fast-growing technology center in North America, attracting startups with a business environment friendly to young companies, and luring top talent with a sophisticated urban lifestyle, extraordinary outdoor amenities, and stunning natural landscapes.